JPH06190020A - Packaged drug - Google Patents

Abstract

(57) [Summary] [Purpose] To provide a packaged drug that enables the visually impaired person to easily identify the dosage and efficacy of the drug in the drug. [Arrangement] A packaged pharmaceutical product in which a pharmaceutical product is contained in a packaging container at least a part of which is formed of a metal film, and a predetermined symbol corresponding to the type and / or dosing condition of the encapsulated pharmaceutical product, A packaged drug provided on the surface of the packaging container as unevenness that can be identified by touch. A packaged medicine in which a medicine is enclosed in a packaging container at least a part of which is composed of a metal film, and the shape and / or number of which is predetermined in accordance with the type and / or dosing conditions of the medicine contained therein. A packaged medicine in which a hole and / or a notch is attached to the packaging container.

Description

Detailed Description of the Invention

[0001]

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a packaged drug product, and more particularly to a packaged drug product that can be easily identified by the visually impaired.

[0002]

2. Description of the Related Art Usually, a medicine received by a patient at a hospital contains a plurality of kinds of medicines, and each medicine may differ in the number of doses taken per day, the timing of administration, the number of doses taken each time, etc. . Many of these medicines have the shape of tablets, pills, capsules, etc., and most of them are PTPs contained in a press-through package.
In the form of packaging (press through pack),
They are similar in appearance and are difficult to distinguish. If you do not carefully observe the color, shape, letters, etc. of the container, the color, shape, size, etc. of the medicine, there is a risk of accidental ingestion and misuse.

However, the colors, shapes, characters, etc. of the containers of these PTP-packaged medicines, the colors, shapes, sizes, etc. of the medicines are all visually recognizable, and visually impaired persons can confirm these indications. I can't. Under these circumstances, when receiving the drug at the hospital, the prescribed dose of the drug,
Even if they receive explanations such as the classification of drug efficacy, patients with visual impairment must make great efforts to take the drug correctly, and there is always a risk of accidental ingestion and misuse. Such a problem for the visually impaired person is not limited to PTP packaged medicines, but is similar to stripped medicines containing suppositories, powders, and divided medicines containing granules.

There is an example in which braille indicating the contents is simply engraved on the outer box of the medical device, and a Braille seal briefly describing the contents is attached to a bag containing capsules for one dose. An example has been reported. However, PT
It is not possible to engrave the Braille description on the P-packed product in terms of space, and it is not easy for an elderly person who becomes blind to learn Braille, and there is a problem that the contents cannot be understood. Furthermore, it would be extremely difficult to display the content of the medication suitable for each patient in Braille in a hospital and give it to the patient in terms of labor and cost.

[0005]

Provided is a packaged drug which enables a visually impaired person to easily discriminate the dose and efficacy of the drug contained therein.

[0006]

The present invention (first invention) is
A packaged pharmaceutical product in which a pharmaceutical product is enclosed in a packaging container at least a part of which is formed of a metal film, and a predetermined symbol corresponding to the type and / or dosing condition of the enclosed pharmaceutical product is the packaging container. The packaged pharmaceutical product is characterized in that it is provided as a concavo-convex pattern that can be distinguished by touch on the surface of.

Another aspect of the present invention (second invention) is a packaged pharmaceutical product in which a pharmaceutical product is contained in a packaging container at least a part of which is composed of a metal film, and the type and / or dosage condition of the encapsulated pharmaceutical product. The packaged pharmaceutical product is characterized in that a predetermined shape and / or number of holes and / or notches corresponding to the above are attached to the packaging container.

Preferred aspects of the present invention are as follows.

(1) The packaged drug as described above, wherein the packaging container is a press-through package.

The packaged pharmaceutical product of the present invention will be described with reference to the accompanying drawings.

FIG. 1 (A) is a perspective view showing an embodiment of a PTP packaged drug, which is an aspect of the packaged drug of the first invention, and FIG. 1 (B) is within a circle X in FIG. 1 (A). FIG. In FIG. 1, a PTP-packaged drug 1 is a press-through package (PTP packaging container) formed by thermocompression bonding a transparent plastic film 3 provided with a recess 2 and an aluminum foil 4 which is a metal film. The tablet 5 is included in the recess 2. A linear convex portion (linear convex portion) 6 and a dot convex portion (dot convex portion) 7 are attached to one end portion of the PTP packaged drug 1. The linear convex portions 6 and the dot-shaped convex portions 7 are formed by pressing from the aluminum foil 4 side, and the concave portions (corresponding to the linear convex portions 6 and the dot-shaped convex portions 7 on the aluminum foil 4 side are recessed ( (Not shown) is formed.

As can be easily understood from FIG. 1, the PTP
The packaged drug 1 in which the linear protrusions 6 and the dot-shaped protrusions 7 are not formed is the same as the conventionally known PTP packaged drug. That is, the PTP packaged drug 1 is a conventionally known PT.
The P-packaged drug has a shape in which a linear convex portion 6 and a point convex portion 7 [both are concaves and convexes that can be distinguished by their antennae (hereinafter sometimes simply referred to as "identification irregularities")] are provided. is doing. Therefore, the PTP-packaged drug 1 is a conventionally known PT.
In the process of manufacturing in the same manner as the method for manufacturing P-packaged drugs,
It can be manufactured by forming the linear protrusions 6 and the dot-shaped protrusions 7.

That is, in general, the conventional PTP-packaged drug is
A transparent plastic film (preferably made of a material such as polyvinyl chloride, polyvinylidene chloride, acetate, polystyrene, or polycarbonate) is heated, and a forming roll is used to form a recess for containing a tablet, Then, tablets are put in the recesses one by one, an aluminum foil is placed on a transparent plastic film, the lid is covered, the both are thermocompression bonded using a sealing roll and a heater roll, and then punching and cutting are performed.

The linear protrusions 6 and the dot-shaped protrusions 7 in the PTP packaged drug 1 are obtained by modifying the press cutter, for example, in the punching process of the conventional manufacturing process of the PTP packaged drug described above. , PTP packaged drug can be formed simultaneously with punching. Further, before or after the punching step, an identification unevenness forming step (for example, using a press) for forming the identification unevenness of the linear convex portions 6 and the dot-shaped convex portions 7 is provided to form the identification unevenness. You may form.
In this case, there is an advantage that the conventionally used apparatus for the punching process can be used as it is. Of course, the formation of the identification unevenness as described above is not limited to the method as described above, and may be performed at any stage of the manufacturing process as necessary.

FIG. 1 shows the linear convex portions 6 and the dot convex portions 7 as the forms of the identification irregularities in the packaged pharmaceutical product of the first invention, but these are merely examples, and The form of the identification unevenness in the invention is not limited to these, and it is not necessary to provide them all.

Next, the identification unevenness in the packaged drug of the first invention will be described. FIG. 2 is a plan view showing another embodiment of the PTP packaged drug which is one mode of the packaged drug of the first invention. In FIG. 2, the PTP packaged drug 11 is formed by thermocompression bonding a transparent plastic film 13 having a recess 12 and an aluminum foil (not shown).
A tablet 14 is included in the recess 12 of the TP packaging container.

A linear (straight and X-shaped) convex portion 15 and a dot-shaped convex portion 16 are provided on the upper end portion of the PTP packaged medicine 11.

The linear protrusions 15 and the dot-shaped protrusions 16 represent symbols (abbreviations) for displaying information such as the type of tablets 14 contained therein and the dosage conditions. That is,
Specific symbols (abbreviations) are shown in Table 1, for example, according to the type of drug (for example, drug efficacy classification) and dosing conditions (for example, number of times of daily use, number of doses at one time, timing of dose, etc.). The tablet 1 is selected from Table 1 in advance.
The symbol corresponding to 4 is selected and attached as the linear convex portion 15 and the dot convex portion 16.

[0019]

[Table 1]

According to the examples shown in Table 1, it can be seen that the tablets 14 contained in the PTP packaged medicine 11 are gout agents and are to be taken 3 times a day. By explaining the contents of Table 1 to the visually impaired patients or passing the contents of Table 1 in Braille to understand the meaning of the unevenness of identification, the visually impaired patients can use the PTP packaged drug 1
By touching the linear convex portions 15 and the dotted convex portions 16 of No. 1 with a fingertip, it becomes possible to recognize the medicinal effect classification and the dose of the tablet 14 contained therein.

In the PTP packaged medicine 11, the places where the linear protrusions 15 and the dot-shaped protrusions 16 are provided are not limited to those shown in FIG. 2, and the original function of the PTP packaged medicine 11 is not impaired. As long as it is any place.

Further, the contents of the information displayed by each of the linear convex portion 15 and the dot convex portion 16 can be arbitrarily changed as required, and these shapes can be changed to irregular shapes having an arbitrary shape. it can. For example, the abbreviation of the linear convex portion 15 may be changed to other irregularities such as characters, figures, symbols, patterns,
Moreover, you may combine these including a linear shape and a dot shape. Needless to say, the meanings of the abbreviations shown in Table 1 can be arbitrarily changed as necessary.

The PTP-packaged drug 11 has a linear convex portion 15
It is not always necessary to provide both the and the point-shaped convex portions 16, and some of them can be omitted. Furthermore, if necessary, one or more of these identification irregularities and / or other identification irregularities that can be recognized by touch (for example, Braille notation).
May be added.

The drug contained in the PTP packaged drug 11 is not limited to the above-mentioned tablets,
It may be any of the solid preparations such as pills, capsules, suppositories, etc., which have conventionally been adopted in the form of PTP packaging.

Next, the packaged drug of the second invention will be described. FIG. 3 shows PT, which is one embodiment of the packaged drug of the second invention.
It is a top view which shows one Example of P packaging pharmaceutical. In FIG. 3, the PTP-packaged medicine 21 has a tablet in a recess 22 of a PTP packaging container formed by thermocompression bonding a transparent plastic film 23 having a recess 22 and an aluminum foil (not shown). 24 is included and configured.

A triangular notch 25 is formed in the upper end portion of the PTP packaged medicine 21.
A triangular hole portion 26 is provided at the center of 1.

As can be easily understood from FIG. 3, the PTP
The packaged drug 21 in which the notch 25 and the hole 26 are not formed is the same as the conventionally known PTP packaged drug. That is, the PTP packaged medicine 21 is different from the conventionally known PTP packaged medicine in the notch portion 25 and the hole portion 26.
It has a shape provided with (all can be identified by the antenna). Therefore, PTP packaged drug 21
Can be manufactured by forming the notch 25 and the hole 26 in the manufacturing process similar to the conventionally known manufacturing method of a PTP packaged drug.

The notch portion 25 and the hole portion 26 in the PTP packaged medicine 21 are used for punching the PTP packaged medicine by modifying the press cutter, for example, in the punching process of the conventional manufacturing process of the PTP packaged medicine. It can be formed at the same time. In addition, before or after the punching step, a step (for example, using a press) for forming the cutout portion 25 and the hole portion 26 may be provided and formed. In this case, there is an advantage that the conventionally used apparatus for the punching process can be used as it is. Of course, the formation of the cutout portion 25 and the hole portion 26 as described above is not limited to the method as described above, and may be performed at any stage of the manufacturing process as needed.

The notch portion 25 and the hole portion 26 represent symbols (abbreviations) for displaying information such as the type of the encapsulated tablet 24 and the dosage conditions. That is, specific symbols (abbreviations) corresponding to the type of drug (for example, drug efficacy classification) and dosing conditions (for example, number of doses per day, number of doses taken at one time, timing of dose, etc.), for example, in the table above As shown in FIG. 1, a symbol corresponding to the tablet 24 is selected from Table 1 and attached as the cutout portion 25 and the hole portion 26.

According to the example shown in Table 1, it can be seen that the tablets 24 contained in the PTP-packaged medicine 21 are taken two at a time before meals. Explain the contents of Table 1 to the visually impaired patients or pass the contents of Table 1 in Braille to understand the meanings of the cutouts and / or holes. The patient can recognize the information about the tablet 24 contained therein by touching the cutout portion 25 and the hole portion 26 of the PTP-packaged medicine 21 with a fingertip. For convenience, the second invention was also described using the example shown in Table 1. However, by appropriately changing the relationship between the information about the drug in Table 1 and the symbols, the patient can obtain other necessary information about the drug. It is also possible to know by touching the notch 25 and the hole 26.

In the PTP packaged medicine 21, the place where the cutout portion 25 and the hole 26 are provided is not limited to that shown in FIG. 3, and other locations can be provided as long as the original function of the PTP packaged medicine 21 is not impaired. It can be anywhere,
Each part can be provided at any place.

Further, the contents of the information displayed by each of the cutout portion 25 and the hole portion 26 can be arbitrarily changed as needed, and these shapes can be changed to arbitrary shapes. For example, the shape of the cutout portion 25 may be semicircular or rectangular, and the hole portion 26 may be changed to circular, rectangular, linear, or the like.

The PTP packaged drug 21 has a cutout 2
It is not always necessary to provide all the holes 5 and the holes 26, and some of them can be omitted. Furthermore, if necessary, one or more of these identification irregularities and / or other identification irregularities that can be recognized by touch (for example, Braille notation) may be added.

The packaged drug of the present invention is a packaged drug in which the drug is contained in a packaging container at least a part of which is composed of a metal film, and the packaged drug corresponds to the type of the drug contained and / or the dosing conditions. The predetermined symbol is
The surface of the packaging container is provided with asperities that can be distinguished by touch, and the packaging container further has a predetermined shape and / or number of holes corresponding to the type and / or dosing conditions of the drug contained in the packaging container. And / or the packaged drug may be provided with a notch.

FIG. 4 is a plan view showing a PTP packaged drug product as an embodiment of the packaged drug product provided with the above-mentioned irregularities and holes and / or notches. In FIG. 4, a PTP-packaged drug 31 is formed by thermocompression bonding a transparent plastic film 33 having a recess 32 and an aluminum foil (not shown), and a tablet 34 is formed in the recess 32. It is included.

At the upper end portion of the PTP packaged medicine 31, linear (straight and X-shaped) convex portions 35, dot-shaped convex portions 36 and triangular notches 37 are formed, and the PTP packaged pharmaceutical 3
A triangular hole 38 is provided in the central portion of 1.

The PTP packaged drug 31 is provided with an uneven portion as in the packaged drug of the first invention and a hole and a notch as in the packaged drug of the second invention. Similar to what has already been described for the invention and the second invention, the linear (straight and cross-shaped) convex portion 35, the dot-shaped convex portion 36, the cutout portion 37, and the hole portion 38 are of a predetermined pharmaceutical product. Information is displayed, and the PTP-packaged medicine 31 can be provided in any place in any number and in any shape.

The packaged drug of the present invention has been described in detail by exemplifying the PTP packaged drug. The packaged drug of the present invention includes a striped drug containing a suppository, a powdered drug, a divided drug containing granules and the like. It may be.

[0039]

EFFECTS OF THE INVENTION Since the packaged medicine of the present invention is provided with parts which can be identified by tactile sensation, such as irregularities, holes, and notches, the visually impaired person is included by the tactile sensation of the fingertip. It is possible to easily confirm the drug efficacy classification and dosage regimen for a drug. Further, the packaged drug of the present invention can be formed in a narrow space because the portion identifiable by the antenna as described above is not formed in Braille, and the patient who receives the drug enclosed in the packaged drug of the present invention However, a large amount of information can be obtained as compared with Braille, and the risk of accidental ingestion and misuse is greatly reduced.

[Brief description of drawings]

FIG. 1 is a perspective view showing an embodiment of a PTP packaged drug, which is an aspect of the packaged drug of the first invention.

FIG. 2 is a plan view showing another embodiment of the PTP packaged drug, which is one mode of the packaged drug of the first invention.

FIG. 3 is a plan view showing an example of a PTP packaged drug, which is an aspect of the packaged drug of the second invention.

FIG. 4 is a plan view showing a PTP packaged drug as an example of the packaged drug provided with irregularities and holes and / or notches.

[Explanation of symbols]

 1 PTP Packaging Pharmaceuticals 2 Recesses 3 Transparent Plastic Film 4 Aluminum Foil 5 Tablets 6 Linear Convex 7 Dots Convex 11 PTP Packaging Pharmaceuticals 12 Recesses 13 Transparent Plastic Film 14 Tablets 15 Linear Convex 16 Dots Convex 21 PTP Packaging Pharmaceuticals 22 Recesses 23 Transparent plastic film 24 Tablets 25 Notches 26 Holes 31 PTP packaging pharmaceuticals 32 Recesses 33 Transparent plastic films 34 Tablets 35 Linear protrusions 36 Dot-convex portions 37 Notches 38 holes

 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Katsumi Saito 4-17-3 East, Kokubunji-cho Station, Shimotsuga-gun, Tochigi Prefecture (72) Inventor Seiji Kondo 10-41, Hatai, Kitaisai-gun, Saitama Prefecture Hatai 10-41 (72) Inventor Toshiyuki Oshima 1-25-14 Teraike, Kanazawa, Ishikawa Prefecture

Claims (4)

[Claims] 1. A packaged pharmaceutical product in which a pharmaceutical product is enclosed in a packaging container at least a part of which is formed of a metal film, and a predetermined symbol corresponding to the type and / or dosing condition of the enclosed pharmaceutical product. On the surface of the packaging container,
A packaged drug characterized by being provided as unevenness that can be identified by touch. 2. The packaged pharmaceutical according to claim 1, wherein the packaging container is a press-through package. 3. A packaged pharmaceutical product in which a pharmaceutical product is contained in a packaging container at least a part of which is formed of a metal film, and a predetermined shape corresponding to the type and / or dosing condition of the encapsulated pharmaceutical product. And / or a number of holes and / or notches are attached to the packaging container. 4. The packaged pharmaceutical according to claim 3, wherein the packaging container is a press-through package.